Zydus Lifesciences Ltd (ZYDUSLIFE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 290229,
    "name": "Zydus Lifesci.",
    "stock_name": "Zydus Lifesci.",
    "full_name": "Zydus Lifesciences Ltd",
    "name_url": "stocks-analysis/zydus-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,074.30",
    "chg": 12.8,
    "chgp": "1.21%",
    "dir": 1,
    "prev_price": "1,061.50",
    "mcapval": "108,658.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532321,
    "symbol": "ZYDUSLIFE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE010B01027",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "13.77 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/zydus-lifesci-290229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Zydus Lifesciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zydus-lifesciences-ltd-latest-results-good-or-bad-4001474",
        "imagepath": "",
        "date": "2026-05-20 19:20:53",
        "description": "Zydus Lifesciences Ltd's latest financial results for Q4 FY25 reflect a complex operational landscape characterized by strong revenue growth alongside margin volatility. The company reported net sales of ₹7,587.00 crores, marking a year-on-year growth of 16.22% and a sequential increase of 10.53%. This revenue surge indicates robust demand dynamics and effective market strategies. However, the operating profit margin, which stood at 34.36%, has shown significant fluctuations throughout the fiscal year, raising concerns about cost management and pricing pressures.\n\nThe consolidated net profit for Q4 FY25 reached ₹1,272.50 crores, representing an 8.68% increase compared to the same period last year. This growth is notable, especially when contrasted with the previous year's decline in net profit. The company’s operating profit, excluding other income, was reported at ₹2,554.40 crores, reflecting a year-on-yea..."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Strong Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-strong-market-positioning-4001171",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4001171.png",
        "date": "2026-05-20 15:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, hitting a new 52-week high and attracting increased investor participation, reflecting growing bullish sentiment."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4001126",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4001126.png",
        "date": "2026-05-20 14:00:08",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, hitting a new 52-week high and attracting increased investor participation, reflecting growing bullish sentiment."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4001080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4001080.png",
        "date": "2026-05-20 13:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, coinciding with robust price gains and heightened investor participation. The pharmaceutical company’s stock hit a new 52-week high of Rs 1,093.65 on 20 May 2026, reflecting growing bullish sentiment and strategic positioning by market participants."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-signalling-bullish-market-positioning-4001041",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4001041.png",
        "date": "2026-05-20 12:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price action, combined with robust volume and open interest growth, suggests increased investor confidence and a possible bullish outlook in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-strong-market-momentum-4000942",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4000942.png",
        "date": "2026-05-20 11:00:06",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market participation and a potential shift in investor sentiment. The pharmaceutical and biotechnology company’s stock has outperformed its sector peers, hitting a new 52-week high of Rs 1,093.65, supported by robust volume and rising investor interest."
      },
      {
        "title": "Zydus Lifesciences Ltd Surges on High-Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-ltd-surges-on-high-value-trading-and-institutional-interest-4000616",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_most_active_equities_by_value_4000616.png",
        "date": "2026-05-20 10:00:10",
        "description": "Zydus Lifesciences Ltd witnessed a robust trading session on 20 May 2026, emerging as one of the most actively traded stocks by value on the bourses. The mid-cap pharmaceutical and biotechnology company recorded a significant 6.33% gain, driven by strong institutional participation and a surge in large order flows, signalling renewed investor confidence in its growth prospects."
      },
      {
        "title": "Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-sharp-open-interest-surge-amid-bullish-momentum-4000620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_oi_spurts_by_underlying_4000620.png",
        "date": "2026-05-20 10:00:07",
        "description": "Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and a potential shift in investor sentiment. The pharmaceutical mid-cap stock not only hit a new 52-week high of Rs 1,083 on 20 May 2026 but also outperformed its sector peers, reflecting robust bullish momentum."
      },
      {
        "title": "Rs 1,100 Calls on Zydus Lifesciences Ltd See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zydus-lifesciences-sees-surge-in-call-option-activity-amid-bullish-momentum-4000552",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZydusLifescienc_most_active_stocks_calls_4000552.png",
        "date": "2026-05-20 10:00:07",
        "description": "On 20 May 2026, 12,866 call contracts at the Rs 1,100 strike price on Zydus Lifesciences Ltd exchanged hands, coinciding with a 6.33% rally in the stock to close near Rs 1,087.55. This synchrony between the options and cash markets highlights a focused directional interest as the expiry date approaches."
      }
    ],
    "total": 15,
    "sid": "290229",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/zydus-lifesciences-290229"
  },
  "announcements": [
    {
      "caption": "Completion Of Merger Of Assertio Holdings Inc.",
      "datetime": "16-Jun-2026",
      "details": "Completion of merger of Assertio Holdings Inc.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "16-Jun-2026",
      "details": "Zydus announces the successful completion of acquisition of Assertio Holdings.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "11-Jun-2026",
      "details": "Newspaper publication of notice of loss of share certificate of the Company published in the Financial Express English and Gujarati Editions both on June 11 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:5</strong> stock split, ex-date: 06 Oct 15",
          "dt": "2015-10-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zydus Lifesciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 05 Apr 10",
          "dt": "2010-04-05",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Zydus Lifesciences Ltd latest results good or bad?

2026-05-20 19:20:53

Zydus Lifesciences Ltd's latest financial results for Q4 FY25 reflect a complex operational landscape characterized by strong revenue growth alongside margin volatility. The company reported net sales of ₹7,587.00 crores, marking a year-on-year growth of 16.22% and a sequential increase of 10.53%. This revenue surge indicates robust demand dynamics and effective market strategies. However, the operating profit margin, which stood at 34.36%, has shown significant fluctuations throughout the fiscal year, raising concerns about cost management and pricing pressures. The consolidated net profit for Q4 FY25 reached ₹1,272.50 crores, representing an 8.68% increase compared to the same period last year. This growth is notable, especially when contrasted with the previous year's decline in net profit. The company’s operating profit, excluding other income, was reported at ₹2,554.40 crores, reflecting a year-on-yea...

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Strong Market Positioning

2026-05-20 15:00:08

Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, hitting a new 52-week high and attracting increased investor participation, reflecting growing bullish sentiment.

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-05-20 14:00:08

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-05-20 13:00:07

Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, coinciding with robust price gains and heightened investor participation. The pharmaceutical company’s stock hit a new 52-week high of Rs 1,093.65 on 20 May 2026, reflecting growing bullish sentiment and strategic positioning by market participants.

Zydus Lifesciences Sees Sharp Open Interest Surge Signalling Bullish Market Positioning

2026-05-20 12:00:07

Zydus Lifesciences Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price action, combined with robust volume and open interest growth, suggests increased investor confidence and a possible bullish outlook in the Pharmaceuticals & Biotechnology sector.

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Strong Market Momentum

2026-05-20 11:00:06

Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market participation and a potential shift in investor sentiment. The pharmaceutical and biotechnology company’s stock has outperformed its sector peers, hitting a new 52-week high of Rs 1,093.65, supported by robust volume and rising investor interest.

Zydus Lifesciences Ltd Surges on High-Value Trading and Institutional Interest

2026-05-20 10:00:10

Zydus Lifesciences Ltd witnessed a robust trading session on 20 May 2026, emerging as one of the most actively traded stocks by value on the bourses. The mid-cap pharmaceutical and biotechnology company recorded a significant 6.33% gain, driven by strong institutional participation and a surge in large order flows, signalling renewed investor confidence in its growth prospects.

Zydus Lifesciences Sees Sharp Open Interest Surge Amid Bullish Momentum

2026-05-20 10:00:07

Zydus Lifesciences Ltd has witnessed a significant surge in open interest (OI) in its derivatives segment, signalling heightened market activity and a potential shift in investor sentiment. The pharmaceutical mid-cap stock not only hit a new 52-week high of Rs 1,083 on 20 May 2026 but also outperformed its sector peers, reflecting robust bullish momentum.

Rs 1,100 Calls on Zydus Lifesciences Ltd See Heavy Activity — What the Strike Price Tells You

2026-05-20 10:00:07

On 20 May 2026, 12,866 call contracts at the Rs 1,100 strike price on Zydus Lifesciences Ltd exchanged hands, coinciding with a 6.33% rally in the stock to close near Rs 1,087.55. This synchrony between the options and cash markets highlights a focused directional interest as the expiry date approaches.

View All News